External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer

Published:2022 Issue:5 Volume:63 Page:531
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Kim Jae Yeon¹^ORCID,Lee Dan Bee¹^ORCID,Song Won Hoon¹²^ORCID,Lee Seung Soo¹²^ORCID,Park Sung Woo¹²^ORCID,Nam Jong Kil¹²^ORCID

Affiliation:

1. Department of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.

2. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.

Publisher

The Korean Urological Association

Subject

Urology

Link

https://icurology.org/pdf/10.4111/icu.20220190

Reference25 articles.

1. International Agency for Research on Cancer. Bladder cancer fact sheet [Internet]. Lyon. International Agency for Research on Cancer. 2020. cited 2021 Sep. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/30-Bladder-fact-sheet.pdf

2. Cancer statistics, 2019

3. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

4. Follow-up procedures for non-muscle-invasive bladder cancer: an update

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of non‐muscle‐invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines;BJUI Compass;2023-11-03

2. Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG‐treated disease;International Journal of Urology;2023-07-31